[Experimental therapy of echinococcosis. 1. Laboratory model of echinococcosis and the effect of sarcolysinacridine, levamisole and mebendazole on the development of larval cysts of Echinococcus granulosus].
D000166:Acridines / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use*; D006224:Cricetinae; D004443:Echinococcosis / Q000188:drug therapy*; D004446:Echinococcus / Q000187:drug effects; D005260:Female; D007814:Larva / Q000254:growth & development; D007978:Levamisole / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008463:Mebendazole / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D011817:Rabbits; D051381:Rats
D000166:Acridines; D001562:Benzimidazoles; D007978:Levamisole; D008463:Mebendazole
Eksperimental'naia terapiia ekhinokokkoza. Soobshchenie I. Laboratornaia model' ekhinokokkoza i vliianie na razvitie larvotsist Echinococcus granulosus sarkolizinakridina, levamizola i mebendazola